voriconazole
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
51 FDA-registered drug labelers
Ajanta Pharma USA Inc.
AKTINOS PHARMA PRIVATE LIMITED
Alivus Life Sciences Limited
American Health Packaging
Amneal Pharmaceuticals LLC
Aurobindo Pharma Limited
AvPAK
Bryant Ranch Prepack
Camber Pharmaceuticals, Inc.
Civica, Inc.
DARMERICA, LLC
Dasami Lab Private Limited
Dr. Reddy's Laboratories Limited
Eugia US LLC
Fosun Pharma USA Inc.
Fresenius Kabi USA, LLC
Gland Pharma Limited
Glenmark Pharmaceuticals Inc., USA
Hainan Poly Pharm. Co., Ltd.
Hetero Labs Limited
Jubilant Biosys limited
Lupin Pharmaceuticals,Inc.
M/s. Lee Pharma Limited
MAEDA INC
Maithri Drugs Private Limited
Major Pharmaceuticals
Matrix Pharmacorp Private Limited
Medichem S.A.
Meitheal Pharmaceuticals Inc.
MSN Laboratories Private Limited
Mylan Institutional Inc.
Mylan Pharmaceuticals Inc.
Neuland Laboratories Limited
NorthStar Rx LLC
Novel Laboratories, Inc.
Patheon Manufacturing Services LLC
Pfizer Ireland Pharmaceuticals Unlimited Company
Professional Compounding Centers of America
Roerig
Sandoz Inc
SIONC PHARMACEUTICALS PVT LTD
Slate Run Pharmaceuticals
Slate Run Pharmaceuticals, LLC
Solco Healthcare U.S., LLC
UBI Pharma Inc.
Viona Pharmaceuticals Inc
Xellia Pharmaceuticals USA LLC
Yung Shin Pharm. Ind. Co., Ltd.
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
Zhejiang Poly Pharm Co., Ltd.
Zydus Lifesciences Limited
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Voriconazole
- •Vfend
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Voriconazole Injection
10/16/2025to be discontinued
Voriconazole Tablet
07/28/2025Vendor Pricing
$86.72/gA2B Chem LLC (1 week)
CountryUnited States
Pack$2168.00 / 25 g
Purity95%
Vendors7 available
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
6 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| AA BLOCKS (1 week) | United States | $92.00 | 25 g | 95% |
| TargetMol Chemicals | China → United States | $532.00 | 500 mg | 99.91% |
| Vitas M Chemical Limited | Hong Kong | $4020.00 | 50 mg | 90% |
| Princeton BioMolecular Research (SC) | United States | $4200.00 | 50 mg | 90% |
| Aaron Chemicals LLC | Hong Kong | $7180.00 | 250 mg | 98% |
| Angene Chemical | China → Hong Kong | $7668.00 | 250 mg | 98% |
Chemical Identity
CAS137234-62-9
PubChem CID71616
DTXSIDDTXSID5046485
FormulaC16H14F3N5O
Mol. Weight349.31 g/mol
SMILESCC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
Data Sources
716162026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/voriconazole/cids/JSON
Archive: data/sources/pubchem_name/voriconazole.json
CAS 137234-62-92026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 137234-62-92026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json